Nu Skin Enterprises Resultados de beneficios anteriores
Pasado controles de criterios 0/6
Nu Skin Enterpriseshan disminuido a un ritmo medio anual de -9.9%, mientras que en la industria Personal Products los ingresos han sido de growing a 20.9% anuales. Los ingresos han sido declining a un ritmo medio de 3.5% al año. Nu Skin Enterprises La rentabilidad de los fondos propios de la empresa es de 7.1% y sus márgenes netos son de 2.9%.
Información clave
-14.7%
Tasa de crecimiento de los beneficios
-12.5%
Tasa de crecimiento del BPA
| Crecimiento de la industria Personal Products | 20.9% |
| Tasa de crecimiento de los ingresos | -4.2% |
| Rentabilidad financiera | 1.0% |
| Margen neto | 0.4% |
| Próxima actualización de resultados | 08 May 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal
Mar 28
Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty
Mar 04We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings
Feb 22Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06
Feb 19Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically
Feb 18Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks
Jan 18Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet
Dec 14Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39
Nov 17Nu Skin: Is It Just A Growth Problem?
Oct 17Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company
Oct 09When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?
Sep 27Nu Skin: Attractive Valuation Trumps Near-Term Risks
Sep 12Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt
Sep 08Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39
Aug 05Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value
Jul 31Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks
Jun 26Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?
Jun 23We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt
May 22Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39
May 07Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital
Apr 26Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching
Mar 18Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39
Feb 19Nu Skin raises quarterly dividend by 1.3% to $0.39/share
Feb 15These 4 Measures Indicate That Nu Skin Enterprises (NYSE:NUS) Is Using Debt Reasonably Well
Feb 12Returns On Capital At Nu Skin Enterprises (NYSE:NUS) Paint A Concerning Picture
Jan 25Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?
Dec 04Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.385
Nov 17Nu Skin: Sell On The Pullback
Oct 06Returns On Capital Signal Tricky Times Ahead For Nu Skin Enterprises (NYSE:NUS)
Sep 27Nu Skin Enterprises (NYSE:NUS) Is Due To Pay A Dividend Of $0.385
Aug 24Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.385
Aug 08What Does Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Indicate?
Jul 24Are Investors Undervaluing Nu Skin Enterprises, Inc. (NYSE:NUS) By 33%?
Jul 10Nu Skin Enterprises cuts Q2 revenue guidance on global headwinds
Jul 07Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero Nu Skin Enterprises. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 23 | 1,969 | 9 | 1,289 | 0 |
| 30 Sep 23 | 2,003 | 59 | 1,292 | 0 |
| 30 Jun 23 | 2,042 | 70 | 1,327 | 0 |
| 31 Mar 23 | 2,102 | 77 | 1,366 | 0 |
| 31 Dec 22 | 2,226 | 105 | 1,435 | 0 |
| 30 Sep 22 | 2,377 | 38 | 1,534 | 0 |
| 30 Jun 22 | 2,480 | 113 | 1,597 | 0 |
| 31 Mar 22 | 2,624 | 139 | 1,682 | 0 |
| 31 Dec 21 | 2,696 | 147 | 1,735 | 0 |
| 30 Sep 21 | 2,770 | 230 | 1,772 | 0 |
| 30 Jun 21 | 2,833 | 237 | 1,801 | 0 |
| 31 Mar 21 | 2,741 | 219 | 1,754 | 0 |
| 31 Dec 20 | 2,582 | 191 | 1,666 | 0 |
| 30 Sep 20 | 2,417 | 158 | 1,590 | 0 |
| 30 Jun 20 | 2,304 | 146 | 1,524 | 0 |
| 31 Mar 20 | 2,315 | 150 | 1,519 | 0 |
| 31 Dec 19 | 2,420 | 174 | 1,572 | 0 |
| 30 Sep 19 | 2,520 | 116 | 1,616 | 0 |
| 30 Jun 19 | 2,606 | 125 | 1,673 | 0 |
| 31 Mar 19 | 2,686 | 129 | 1,731 | 0 |
| 31 Dec 18 | 2,679 | 122 | 1,733 | 0 |
| 30 Sep 18 | 2,662 | 158 | 1,720 | 0 |
| 30 Jun 18 | 2,550 | 146 | 1,661 | 0 |
| 31 Mar 18 | 2,396 | 137 | 1,572 | 0 |
| 31 Dec 17 | 2,279 | 129 | 1,503 | 0 |
| 30 Sep 17 | 2,144 | 149 | 1,446 | 0 |
| 30 Jun 17 | 2,185 | 165 | 1,463 | 0 |
| 31 Mar 17 | 2,235 | 167 | 1,492 | 0 |
| 31 Dec 16 | 2,208 | 143 | 1,476 | 0 |
| 30 Sep 16 | 2,249 | 141 | 1,503 | 0 |
| 30 Jun 16 | 2,216 | 100 | 1,483 | 0 |
| 31 Mar 16 | 2,176 | 100 | 1,469 | 0 |
| 31 Dec 15 | 2,247 | 133 | 1,513 | 0 |
| 30 Sep 15 | 2,284 | 144 | 1,536 | 0 |
| 30 Jun 15 | 2,352 | 196 | 1,584 | 0 |
| 31 Mar 15 | 2,442 | 171 | 1,645 | 0 |
| 31 Dec 14 | 2,569 | 189 | 1,739 | 0 |
| 30 Sep 14 | 3,016 | 268 | 2,030 | 0 |
| 30 Jun 14 | 3,285 | 311 | 2,205 | 0 |
| 31 Mar 14 | 3,306 | 365 | 2,211 | 0 |
| 31 Dec 13 | 3,177 | 365 | 2,117 | 0 |
| 30 Sep 13 | 2,672 | 299 | 1,781 | 0 |
| 30 Jun 13 | 2,290 | 242 | 1,538 | 0 |
Ingresos de calidad: NUS tiene un gran one-off loss de $30.5M impacto en sus últimos 12 meses de resultados financieros a 30th September, 2023.
Margen de beneficios creciente: NUSLos actuales márgenes de beneficio netos de (0.4%) son inferiores a los del año pasado (4.7%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: NUSLos beneficios de la empresa han disminuido en 9.9% al año en los últimos 5 años.
Acelerando crecimiento: NUS's ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: NUS tuvo un crecimiento negativo de los beneficios (-91.8%) durante el año pasado, lo que dificulta la comparación con la media del sector Personal Products (-8.1%).
Rentabilidad financiera
Alto ROE: El Retorno sobre el capital de NUS (7.1%) se considera bajo.